Total investments received (USD): 49.28m
Round value (USD): 6.77m
Round investors:
Vesalius Biocapital Partners
Company: Enyo Pharma




Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
Ireland
Italy
Portugal
Spain
United Kingdom